While detailed information on the specific synthesis, effects, and importance of (4-nitrophenyl)vinyl ether is scarce in readily available research databases, its structure suggests potential for applications in organic synthesis and material science. The nitro group on the phenyl ring imparts electron-withdrawing properties, which could make the compound a useful building block for creating functionalized molecules. The vinyl ether functionality is also known for its reactivity, potentially leading to its use in various chemical transformations. Further investigation into the properties and applications of (4-nitrophenyl)vinyl ether is necessary to fully understand its potential.'
| ID Source | ID |
|---|---|
| PubMed CID | 119042 |
| SCHEMBL ID | 830158 |
| MeSH ID | M0137584 |
| Synonym |
|---|
| ccris 2897 |
| ether, p-nitrophenyl vinyl |
| (4-nitrophenyl)vinyl ether |
| p-nitrophenyl vinyl ether |
| 1-(ethenyloxy)-4-nitrobenzene |
| 4-nitrophenyl vinyl ether |
| vinyl p-nitrophenyl ether |
| benzene, 1-(ethenyloxy)-4-nitro- |
| inchi=1/c8h7no3/c1-2-12-8-5-3-7(4-6-8)9(10)11/h2-6h,1h |
| 940-14-7 |
| 1-ethenoxy-4-nitrobenzene |
| AKOS006278228 |
| 1-nitro-4-(vinyloxy)benzene |
| ba6lq39mhh , |
| (para-nitrophenyl)vinyl ether |
| unii-ba6lq39mhh |
| SCHEMBL830158 |
| DTXSID90240190 |
| 1-nitro-4-vinyloxy-benzene |
| CS-0242227 |
| EN300-246227 |
| Excerpt | Reference | Relevance |
|---|---|---|
| " These results showed that aryl vinyl ethers, NPVE and PVE, are more toxic than the alkyl vinyl ether, BVE, and that glutathione plays an important role on the protection of hepatic injury by reactive metabolite(s) derived from vinyl ethers." | ( Depletion of glutathione and hepato-toxicity caused by vinyl ethers in mice. Isobe, M; Sone, T; Takabatake, E, 1995) | 0.29 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.46) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||